Cost-effectiveness of HIV treatment as prevention in serodiscordant couples.

Publication Type:

Journal Article

Source:

The New England journal of medicine, Volume 369, Issue 18, p.1715-25 (2013)

Keywords:

2013, Adult, Anti-Retroviral Agents, Cost-Benefit Analysis, Disease Transmission, Infectious, Drug Administration Schedule, Female, Gross Domestic Product, Health Care Costs, HIV Infections, Humans, India, Male, November 2013, South Africa, Vaccine and Infectious Disease Division

Abstract:

The cost-effectiveness of early antiretroviral therapy (ART) in persons infected with human immunodeficiency virus (HIV) in serodiscordant couples is not known. Using a computer simulation of the progression of HIV infection and data from the HIV Prevention Trials Network 052 study, we projected the cost-effectiveness of early ART for such persons.